Search
for
Sort by
Research 691–720 of 1000+
- History of discovery of polycystic ovary syndrome
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Neurosteroid-sensitive δ-GABA<sub>A</sub>receptors: A role in epileptogenesis?
- Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
- A Comprehensive Review of Acne Vulgaris
- The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Menopausal Acne – Challenges And Solutions
- Role of Oxidative Stress in Obese and Nonobese PCOS Patients
- Skin disease related to metabolic syndrome in women
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment
- Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study
- Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management
- Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature
- Case Report: Disorder of Sexual Development in a Chinese Crested Dog With XX/XY Leukocyte Chimerism and Mixed Cell Testicular Tumors
- The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
- Novel Androgen Receptor Gene Variant Containing a Premature Termination Codon in a Patient with Androgen Insensitivity Syndrome
- Lean Women with Polycystic Ovary Syndrome
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Adrenocortical Adenocarcinoma in a Syrian Golden Hamster ( <i>Mesocricetus auratus)</i> With Suspected Hyperadrenocorticism
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Effects of Probiotic Supplementation on Mental Health and the Risk of Depression in Women with Polycystic Ovary Syndrome: A Systematic Review of Randomized Controlled Trials
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives